Team:StanfordBrownSpelman/Human Practices
From 2014.igem.org
(Difference between revisions)
Line 109: | Line 109: | ||
<div class="row"> | <div class="row"> | ||
<div id="subheader" class="small-8 small-centered columns"> | <div id="subheader" class="small-8 small-centered columns"> | ||
- | <h5><center>Our Work with the EPA</h5> | + | <h5><center>Our Work with the EPA: Synthetic biology in the air: Biological UAVs and environmental safety concerns</h5> |
<h6> | <h6> | ||
- | + | ||
We are currently working on a series of projects towards the construction of a fully biological unmanned aerial vehicle (UAV) for use in scientific and humanitarian missions. The prospect of a biologically-produced UAV presents numerous advantages over the current manufacturing paradigm. First, a foundational architecture built by cells allows for construction or repair in locations where it would be difficult to bring traditional tools of production. Second, a major limitation of current research with UAVs is the size and high power consumption of analytical instruments, which require bulky electrical components and large fuselages to support their weight. By moving these functions into cells with biosensing capabilities – for example, a series of cells engineered to report GFP, green fluorescent protein, when conditions exceed a certain threshold concentration of a compound of interest, enabling their detection post-flight – these problems of scale can be avoided. | We are currently working on a series of projects towards the construction of a fully biological unmanned aerial vehicle (UAV) for use in scientific and humanitarian missions. The prospect of a biologically-produced UAV presents numerous advantages over the current manufacturing paradigm. First, a foundational architecture built by cells allows for construction or repair in locations where it would be difficult to bring traditional tools of production. Second, a major limitation of current research with UAVs is the size and high power consumption of analytical instruments, which require bulky electrical components and large fuselages to support their weight. By moving these functions into cells with biosensing capabilities – for example, a series of cells engineered to report GFP, green fluorescent protein, when conditions exceed a certain threshold concentration of a compound of interest, enabling their detection post-flight – these problems of scale can be avoided. |
Revision as of 21:40, 30 September 2014